Identification and evaluation of a novel glucokinase allosteric activator in target cells and animal model of type 2 diabetes

被引：0
|
作者：
Nagata, Y
Sasaki, K
Hosaka, H
Ooyama, S
Kadotani, A
Goto, H
Futamura, M
Nishimura, T
Iino, T
Bamba, M
Watanabe, H
Suzuki, J
Li, ZH
Moller, DE
Zhang, BB
Eiki, JI
机构：
来源：
DIABETES | 2004年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A139 / A139
页数：1
相关论文
共 50 条
  • [1] Identification of YH-GKA, a novel benzamide glucokinase activator as therapeutic candidate for type 2 diabetes mellitus
    Kaapjoo Park
    Archives of Pharmacal Research, 2012, 35 : 2029 - 2033
  • [2] Identification of YH-GKA, a novel benzamide glucokinase activator as therapeutic candidate for type 2 diabetes mellitus
    Park, Kaapjoo
    ARCHIVES OF PHARMACAL RESEARCH, 2012, 35 (12) : 2029 - 2033
  • [3] Targeting human Glucokinase for the treatment of type 2 diabetes: an overview of allosteric Glucokinase activators
    Sharma, Prateek
    Singh, Sukhbir
    Sharma, Neelam
    Singla, Deepak
    Guarve, Kumar
    Grewal, Ajmer Singh
    JOURNAL OF DIABETES AND METABOLIC DISORDERS, 2022, 21 (01) : 1129 - 1137
  • [4] Targeting human Glucokinase for the treatment of type 2 diabetes: an overview of allosteric Glucokinase activators
    Prateek Sharma
    Sukhbir Singh
    Neelam Sharma
    Deepak Singla
    Kumar Guarve
    Ajmer Singh Grewal
    Journal of Diabetes & Metabolic Disorders, 2022, 21 : 1129 - 1137
  • [5] Discovery of a novel phenylethyl benzamide glucokinase activator for the treatment of type 2 diabetes mellitus
    Park, Kaapjoo
    Lee, Byoung Moon
    Kim, Young Hwan
    Han, Taedong
    Yi, Wonhui
    Lee, Dong Hoon
    Choi, Hyun Ho
    Chong, Wonee
    Lee, Chun Ho
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (02) : 537 - 542
  • [6] Identification of RO4597014, a Glucokinase Activator Studied in the Clinic for the Treatment of Type 2 Diabetes
    Qian, Yimin
    Corbett, Wendy L.
    Berthel, Steven J.
    Choi, Duk Soon
    Dvorozniak, Mark T.
    Geng, Wanping
    Gillespie, Paul
    Guertin, Kevin R.
    Haynes, Nancy-Ellen
    Kester, Robert F.
    Mennona, Francis A.
    Moore, David
    Racha, Jagdish
    Radinov, Roumen
    Sarabu, Ramakanth
    Scott, Nathan R.
    Grimsby, Joseph
    Mallalieu, Navita L.
    ACS MEDICINAL CHEMISTRY LETTERS, 2013, 4 (04): : 414 - 418
  • [7] Effects of a Novel Glucokinase Activator, HMS5552, on Glucose Metabolism in a Rat Model of Type 2 Diabetes Mellitus
    Wang, Ping
    Liu, Huili
    Chen, Li
    Duan, Yingli
    Chen, Qunli
    Xi, Shoumin
    JOURNAL OF DIABETES RESEARCH, 2017, 2017
  • [8] Discovery of ARRY-588, a novel glucokinase activator with potent glucose-lowering activity in animal models of type 2 diabetes mellitus
    Aicher, Thomas
    Boyd, Steven
    Anderson, Debbie
    Chicarelli, Mark
    Condroski, Kevin
    Dewolf, Walter, Jr.
    Fell, Jay B.
    Fischer, John
    Galbraith, Sarah
    Garrey, Rustai
    Gunawardana, Indrani
    Hinklin, Ronald
    Hirsch, Jessica
    Lee, Patrice
    Neitzel, Nicolas
    Pratt, Scott
    Singh, Ajay
    Sullivan, Francis
    Turner, Timothy
    Voegtli, Walter
    Wallace, Eli
    Williams, Lance
    DIABETES, 2008, 57 : A139 - A139
  • [9] AZD1656, a novel glucokinase activator, lowers plasma glucose in patients with type 2 diabetes
    Morrow, L.
    Leonsson-Zachrisson, M.
    Ericsson, H.
    Wollbratt, M.
    Knutsson, M.
    Hompesch, M.
    Norjavaara, E.
    DIABETOLOGIA, 2011, 54 : S361 - S362
  • [10] Efficacy and safety of novel dual glucokinase activator dorzagliatin in type-2 diabetes A meta-analysis
    Dutta, Deep
    Khandelwal, Deepak
    Kumar, Manoj
    Sharma, Meha
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2023, 17 (01)
12345